Zymeworks (ZYME) Other Accumulated Expenses (2021)
Zymeworks (ZYME) posted Other Accumulated Expenses of $22000.0 for Q4 2021.
Powered by 
Analysis
Zymeworks (ZYME) Other Accumulated Expenses (2021) Analysis & Trends
Zymeworks has reported Other Accumulated Expenses for 1 years, with the latest figure at $22000.0 in Q4 2021.
- Quarterly Other Accumulated Expenses changed N/A year-over-year to $22000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $22000.0 (changed N/A YoY) and the FY2021 annual result came in at $22000.0, changed N/A from the prior year.
- Other Accumulated Expenses was little changed at $22000.0 in Q4 2021 per ZYME's latest filing.
- Over five years, Other Accumulated Expenses peaked at $22000.0 in Q4 2021 and troughed at $22000.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Zymeworks | 2.15 Bn | 1.88 Bn | - |